APLS: Apellis Pharmaceuticals, Inc. Stock

by  •  • Comments Off on APLS: Apellis Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 5,779.48
Enterprise Value ($M) 5,521.33
Book Value ($M) 194.52
Book Value / Share 1.61
Price / Book 29.71
NCAV ($M) 172.12
NCAV / Share 1.43
Price / NCAV 33.58

Profitability (mra)
Return on Invested Capital (ROIC) -1.73
Return on Assets (ROA) -0.54
Return on Equity (ROE) -1.28

Liquidity (mrq)
Quick Ratio 2.44
Current Ratio 3.10

Balance Sheet (mrq) ($M)
Current Assets 766.33
Assets 788.73
Liabilities 594.21
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 396.59
Operating Income -517.12
Net Income -528.63
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -594.74
Cash from Investing -0.67
Cash from Financing 394.50

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A EcoR1 Capital, LLC 9.40 77.14
02-14 13G/A Avoro Capital Advisors LLC 9.90 26.22
02-14 13G T. Rowe Price Investment Management, Inc. 5.30 7.89
02-13 13G/A Vanguard Group Inc 8.06 3.73
02-08 13G/A Wellington Management Group Llp 13.91 11.56
07-07 13G/A BlackRock Inc. 4.90 -25.40

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 220,523 337,545 65.33
2024-04-25 219,044 383,646 57.10
2024-04-24 168,312 401,271 41.94
2024-04-23 281,827 318,882 88.38

(click for more detail)

Similar Companies
AMRX – Amneal Pharmaceuticals, Inc. ANAB – AnaptysBio, Inc.
ANNX – Annexon, Inc. ARQT – Arcutis Biotherapeutics, Inc.
ARVN – Arvinas, Inc.


Financial data and stock pages provided by
Fintel.io